周三，美国远程医疗公司 Teladoc Health Inc.股价走高，盘中涨幅超9%。消息面上，上周知名做空机构Citron Research罕见发表看多评论，称他们“并非看错，只是看早”，重申对该公司长期潜力的信心。
Teladoc近年来在数字医疗与虚拟诊疗领域深耕，尽管股价自新冠疫情高点回落，机构分析人士指出，随着医疗保险和企业健康计划的数字化转型加速，该公司有望迎来新的增长契机。
周三，美国远程医疗公司 Teladoc Health Inc.股价走高，盘中涨幅超9%。消息面上，上周知名做空机构Citron Research罕见发表看多评论，称他们“并非看错，只是看早”，重申对该公司长期潜力的信心。
Teladoc近年来在数字医疗与虚拟诊疗领域深耕，尽管股价自新冠疫情高点回落，机构分析人士指出，随着医疗保险和企业健康计划的数字化转型加速，该公司有望迎来新的增长契机。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.